Galera Therapeutics Inc. (NASDAQ:GRTX) has a beta value of 0 and has seen 1,330,960 shares traded in the last trading session. The company, currently valued at $205.82 Million, closed the last trade at $8.15 per share which meant it gained $0.03 on the day or 0.37% during that session. The GRTX stock price is -84.05% off its 52-week high price of $15 and 19.26% above the 52-week low of $6.58. If we look at the company’s 10-day average daily trading volume, we find that it stood at 72.53 Million shares traded. The 3-month trading volume is 65.29 Million shares.
The consensus among analysts is that Galera Therapeutics Inc. (GRTX) is a Buy stock at the moment, with a recommendation rating of 1.4. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 5 have rated it as a Hold, with 5 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.83.
Galera Therapeutics Inc. (NASDAQ:GRTX) trade information
Sporting 0.37% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Apr 29 when the GRTX stock price touched $10.11- or saw a rise of 19.39%. Year-to-date, Galera Therapeutics Inc. shares have moved -20.33%, while the 5-day performance has seen it change 24.24%. Over the past 30 days, the shares of Galera Therapeutics Inc. (NASDAQ:GRTX) have changed -2.4%. Short interest in the company has seen 160.6 Million shares shorted with days to cover at 2.46.
Wall Street analysts have a consensus price target for the stock at $19.6, which means that the shares’ value could jump 140.49% from current levels. The projected low price target is $15 while the price target rests at a high of $30. In that case, then, we find that the current price level is +268.1% off the targeted high while a plunge would see the stock lose 84.05% from current levels.
Galera Therapeutics Inc. (GRTX) estimates and forecasts
Earnings growth for 2021 is a modest -25.3% while over the next 5 years, the company’s earnings are expected to increase by 21.2%.
Galera Therapeutics Inc. (NASDAQ:GRTX)’s Major holders
Insiders own 11.42% of the company shares, while shares held by institutions stand at 75.55% with a share float percentage of 85.28%. Investors are also buoyed by the number of investors in a company, with Galera Therapeutics Inc. having a total of 77 institutions that hold shares in the company. The top two institutional holders are NEA Management Company, LLC with over 4.36 Million shares worth more than $44.63 Million. As of December 30, 2020, NEA Management Company, LLC held 17.47% of shares outstanding.
The other major institutional holder is Sofinnova Investments Inc., with the holding of over 3.08 Million shares as of December 30, 2020. The firm’s total holdings are worth over $31.55 Million and represent 12.35% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Tekla Healthcare Opportunities Fund and Tekla Healthcare Investors. As of December 30, 2020, the former fund manager holds about 1.46% shares in the company for having 364646 shares of worth $3.73 Million while later fund manager owns 343.81 Thousand shares of worth $3.52 Million as of December 30, 2020, which makes it owner of about 1.38% of company’s outstanding stock.